Alkylating Drug [EPC]

243979 reported adverse events

Drugs of this class: TEMOZOLOMIDE MITOMYCIN THIOTEPA BUSULFAN IFOSFAMIDE LOMUSTINE DACARBAZINE CYCLOPHOSPHAMIDE TRABECTEDIN CARMUSTINE CHLORAMBUCIL

These side effects are most commonly reported by patients taking drugs of the Alkylating Drug [EPC] class:

# Side effect Count
0 OFF LABEL USE 22823
1 FEBRILE NEUTROPENIA 18970
2 NEUTROPENIA 14289
3 DRUG INEFFECTIVE 14044
4 PYREXIA 12159
5 DISEASE PROGRESSION 11684
6 THROMBOCYTOPENIA 10306
7 PRODUCT USE IN UNAPPROVED INDICATION 9754
8 NAUSEA 9357
9 ANAEMIA 8594
See all common reactions for Alkylating Drug [EPC]

Drugs of the Alkylating Drug [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 1374 0.6226
1 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 1373 0.4962
2 ACUTE GRAFT VERSUS HOST DISEASE 2074 0.4526
3 VENOOCCLUSIVE DISEASE 1084 0.4326
4 CYTOMEGALOVIRUS INFECTION REACTIVATION 1768 0.3998
5 VENOOCCLUSIVE LIVER DISEASE 1939 0.3923
6 CHRONIC GRAFT VERSUS HOST DISEASE 1407 0.3893
7 HUMAN HERPESVIRUS 6 INFECTION 720 0.3805
8 GRAFT VERSUS HOST DISEASE IN SKIN 834 0.3782
9 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 778 0.3653
See all enriched reactions for Alkylating Drug [EPC]